Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Distress is highly prevalent among patients with cancer, but supportive care needs often go unmet. Digital therapeutics hold the potential to overcome barriers in cancer care and improve health outcomes. Objective: This study conducted a randomized controlled trial to investigate the efficacy of Mika, an app-based digital therapeutic designed to reduce distress across the cancer trajectory. Methods: This nationwide waitlist randomized controlled trial in Germany enrolled patients with cancer across all tumor entities diagnosed within the last 5 years. Participants were randomized into the intervention (Mika plus usual care) and control (usual care alone) groups. The participants completed web-based assessments at baseline and at 2, 6, and 12 weeks. The primary outcome was the change in distress from baseline to week 12, as measured by the National Comprehensive Cancer Network Distress Thermometer. Secondary outcomes included depression, anxiety (Hospital Anxiety and Depression Scale), fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue), and quality of life (Clinical Global Impression-Improvement Scale). Intention-to-treat and per-protocol analyses were performed. Analyses of covariance were used to test for outcome changes over time between the groups, controlling for baseline. Results: A total of 218 patients (intervention: n=99 and control: n=119) were included in the intention-to-treat analysis. Compared with the control group, the intervention group reported greater reductions in distress (P=.03; ηp²=0.02), depression (P<.001; ηp²=0.07), anxiety (P=.03; ηp²=0.02), and fatigue (P=.04; ηp²=0.02). Per-protocol analyses revealed more pronounced treatment effects, with the exception of fatigue. No group difference was found for quality of life. Conclusions: Mika effectively diminished distress in patients with cancer. As a digital therapeutic solution, Mika offers accessible, tailored psychosocial and self-management support to address the unmet needs in cancer care. Trial Registration: German Clinical Trials Register (DRKS) DRKS00026038; https://drks.de/search/en/trial/DRKS00026038
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593 · cited 1×
“The app incorporates evidence-based supportive care elements, such as distress and symptom monitoring [32], CBT-based coping skills training [33], mindfulness-based stress reduction (MBSR) [34,35], strength and flexibility training [36], and patient education [37], thus targeting different aspects…”
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449 · cited 1×
“In addition to somatic symptoms such as pain [1], patients with cancer report elevated levels of distress, anxiety, and depression [2,3].”
Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200009000-00004 · Cited by 1,082 · cited 1×
“…supportive care elements, such as distress and symptom monitoring [32], CBT-based coping skills training [33], mindfulness-based stress reduction (MBSR) [34,35], strength and flexibility training [36], and patient education [37], thus targeting different aspects of psychological distress.”
Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8922 · Cited by 912 · cited 2×
“Supportive care interventions to prevent and manage the adverse psychological and physical effects of cancer across the cancer trajectory effectively improve outcomes such as emotional distress, QoL, and fatigue [6].”
Carlson, L. E., Speca, M., Faris, P., & Patel, K. D. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.04.002 · Cited by 688 · cited 1×
“…supportive care elements, such as distress and symptom monitoring [32], CBT-based coping skills training [33], mindfulness-based stress reduction (MBSR) [34,35], strength and flexibility training [36], and patient education [37], thus targeting different aspects of psychological distress.”
One in two cancer patients is significantly distressed: Prevalence and indicators of distress
Mehnert, A., Hartung, T. J., Friedrich, M., Vehling, S., Brähler, E., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4464 · Cited by 615 · cited 2×
“In addition to somatic symptoms such as pain [1], patients with cancer report elevated levels of distress, anxiety, and depression [2,3].”
Self-citationHospital anxiety and depression scale, Deutsche version (HADS-D)
Petermann, F. (2011) · Zeitschrift für Psychiatrie, Psychologie und Psychotherapie · doi:10.1024/1661-4747/a000077 · Cited by 558
Mehnert, A., Müller, D., Lehmann, C., & Koch, U. (2006) · Zeitschrift für Psychiatrie, Psychologie und Psychotherapie · doi:10.1024/1661-4747.54.3.213 · Cited by 440
Tauber, N. M., O’Toole, M. S., Dinkel, A., Galica, J., Humphris, G., Lebel, S., Maheu, C., Ozakinci, G., Prins, J., Sharpe, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00572 · Cited by 402
Cillessen, L., Johannsen, M., Speckens, A. E. M., & Zachariae, R. (2019) · Psycho-Oncology · doi:10.1002/pon.5214 · Cited by 326 · cited 1×
“…a large body of data shows that while variables such as cancer type, treatment status, disease progression, and sex may influence the magnitude of treatment response to supportive therapy, the beneficial effects of supportive therapy are present across various cancer subpopulations [65-67].”
Carpenter, J. R., Roger, J. H., & Kenward, M. G. (2013) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.834911 · Cited by 286 · cited 1×
“…to model the robustness of the primary efficacy analysis under different assumptions for missing data mechanisms, an explorative sensitivity analysis using reference-based multiple imputation (jump-to-reference) [48] was performed in the extended ITT population (all randomized participants).”
The increasing value of eHealth in the delivery of patient-centred cancer care
Penedo, F. J., Oswald, L. B., Kronenfeld, J. P., Garcia, S. F., Cella, D., & Yanez, B. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30021-8 · Cited by 252 · cited 2×
“…multiple benefits: they facilitate easy and low-threshold access to care, can overcome barriers to care (eg, location, time, and health status), may enhance symptom management through real-time symptom assessment, are scalable, and provide cost-effective and efficient information sharing [14].”
Psychological Distress and Cancer Survival: A Follow-Up 10 Years After Diagnosis
Brown, K. W., Levy, A. R., Rosberger, Z., & Edgar, L. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000077503.96903.a6 · Cited by 213
Jansen, F., van Uden-Kraan, C. F., van Zwieten, V., Witte, B. I., & Verdonck-de Leeuw, I. M. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2514-7 · Cited by 195
Primary Health and Supportive Care Needs of Long-Term Cancer Survivors: A Questionnaire Survey
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., Forman, D., Roche, M. F., & Rose, P. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5167 · Cited by 176
Kumar, P., Casarett, D., Corcoran, A., Desai, K., Li, Q., Chen, J., Langer, C., & Mao, J. J. (2012) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.0217 · Cited by 141 · cited 1×
“However, access to supportive care is often limited by a lack of specialist staff, organizational deficiencies, and barriers that cause patients to avoid or delay their treatment [8-10].”
Nissen, E. R., O'Connor, M., Kaldo, V., Højris, I., Borre, M., Zachariae, R., & Mehlsen, M. (2020) · Psycho-Oncology · doi:10.1002/pon.5237 · Cited by 136
Merluzzi, T. V., Pustejovsky, J. E., Philip, E. J., Sohl, S. J., Berendsen, M., & Salsman, J. M. (2019) · Psycho-Oncology · doi:10.1002/pon.5148 · Cited by 122 · cited 1×
“…a large body of data shows that while variables such as cancer type, treatment status, disease progression, and sex may influence the magnitude of treatment response to supportive therapy, the beneficial effects of supportive therapy are present across various cancer subpopulations [65-67].”
Greer, J. A., Jacobs, J., Pensak, N., MacDonald, J. J., Fuh, C.-X., Perez, G. K., Ward, A., Tallen, C., Muzikansky, A., Traeger, L., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0536 · Cited by 112 · cited 4×
“In contrast to the findings of this study, however, other studies found an effect of app-based supportive interventions on QoL [23,27,31].”
InfluentialGhanbari, E., Yektatalab, S., & Mehrabi, M. (2021) · JMIR mHealth and uHealth · doi:10.2196/19262 · Cited by 104
Lengacher, C. A., Reich, R. R., Ramesar, S., Alinat, C. B., Moscoso, M., Cousin, L., Marino, V. R., Elias, M. N., Paterson, C. L., Pleasant, M. L., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4491 · Cited by 101 · cited 4×
“In contrast to the findings of this study, however, other studies found an effect of app-based supportive interventions on QoL [23,27,31].”
InfluentialMatis, J., Svetlak, M., Slezackova, A., Svoboda, M., & Šumec, R. (2020) · doi:10.2196/preprints.20709 · Cited by 81
Ham, K., Chin, S., Suh, Y. J., Rhee, M., Yu, E.-S., Lee, H. J., Kim, J.-H., Kim, S. W., Koh, S.-J., & Chung, K.-M. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01592 · Cited by 61 · cited 2×
“…shows evidence of the efficacy of app-based interventions for oncological populations on distress, fatigue, anxiety, and depression [20,25,27,31,51], this is the first study to examine the efficacy of a single holistic app-based digital therapeutic based on multiple intervention modules on…”
Mikolasek, M., Witt, C. M., & Barth, J. (2021) · JMIR Cancer · doi:10.2196/16785 · Cited by 36
Cited by
von Lützow, U., Neuendorf, N. L., & Scherr, S. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2025-301641 · Cited by 29
Nezenega, Z. S., Aychiluhm, S. B., Ross, A. G., Kassa, Z. Y., Bore, M. G., Leshargie, C. T., Allan, J., Thapa, S., Astawesegn, F. H., Mahmood, S., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02266-x · Cited by 13
Springer, F., Hambsch, P. K., Mehnert-Theuerkauf, A., & Nicolay, N. H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1546221 · Cited by 5
Self-citationKılınç, N. D., & Oflaz, F. (2026) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20251636
Metadata
- Authors
- Springer, F., Maier, A., Friedrich, M., Raue, J. S., Finke, G., Lordick, F., Montgomery, G., Esser, P., Brock, H., & Mehnert-Theuerkauf, A.
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2024-04-25
- Volume
- 26
- Pages
- e51949
- ISSN
- 1438-8871 (ISSN-L)
- OpenAlex
- W4392107943
- Cited by
- 34
- References
- 24
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.